Direkt zum Inhalt
Merck

Modular basis for potent SARS-CoV-2 neutralization by a prevalent VH1-2-derived antibody class.

Cell reports (2021-04-02)
Micah Rapp, Yicheng Guo, Eswar R Reddem, Jian Yu, Lihong Liu, Pengfei Wang, Gabriele Cerutti, Phinikoula Katsamba, Jude S Bimela, Fabiana A Bahna, Seetha M Mannepalli, Baoshan Zhang, Peter D Kwong, Yaoxing Huang, David D Ho, Lawrence Shapiro, Zizhang Sheng
ZUSAMMENFASSUNG

Antibodies with heavy chains that derive from the VH1-2 gene constitute some of the most potent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-neutralizing antibodies yet identified. To provide insight into whether these genetic similarities inform common modes of recognition, we determine the structures of the SARS-CoV-2 spike in complex with three VH1-2-derived antibodies: 2-15, 2-43, and H4. All three use VH1-2-encoded motifs to recognize the receptor-binding domain (RBD), with heavy-chain N53I-enhancing binding and light-chain tyrosines recognizing F486RBD. Despite these similarities, class members bind both RBD-up and -down conformations of the spike, with a subset of antibodies using elongated CDRH3s to recognize glycan N343 on a neighboring RBD-a quaternary interaction accommodated by an increase in RBD separation of up to 12 Å. The VH1-2 antibody class, thus, uses modular recognition encoded by modular genetic elements to effect potent neutralization, with the VH-gene component specifying recognition of RBD and the CDRH3 component specifying quaternary interactions.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
HRV-3C-Protease, N-Terminal His tagged recombinant protein, aqueous solution, 0.8-1.2 mg/mL